Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP834470.RA8C1vE6gI8aKLcwPcA3LzIvOSEqcgpylt7pxMwr9_KuE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP834470.RA8C1vE6gI8aKLcwPcA3LzIvOSEqcgpylt7pxMwr9_KuE130_assertion type Assertion NP834470.RA8C1vE6gI8aKLcwPcA3LzIvOSEqcgpylt7pxMwr9_KuE130_head.
- NP834470.RA8C1vE6gI8aKLcwPcA3LzIvOSEqcgpylt7pxMwr9_KuE130_assertion description "[We have employed chimeric antisense oligonucleotides to investigate the molecular alterations after targeted interference with Plk1 in RKO human colon adenocarcinoma and PC3 prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP834470.RA8C1vE6gI8aKLcwPcA3LzIvOSEqcgpylt7pxMwr9_KuE130_provenance.
- NP834470.RA8C1vE6gI8aKLcwPcA3LzIvOSEqcgpylt7pxMwr9_KuE130_assertion evidence source_evidence_literature NP834470.RA8C1vE6gI8aKLcwPcA3LzIvOSEqcgpylt7pxMwr9_KuE130_provenance.
- NP834470.RA8C1vE6gI8aKLcwPcA3LzIvOSEqcgpylt7pxMwr9_KuE130_assertion SIO_000772 16648550 NP834470.RA8C1vE6gI8aKLcwPcA3LzIvOSEqcgpylt7pxMwr9_KuE130_provenance.
- NP834470.RA8C1vE6gI8aKLcwPcA3LzIvOSEqcgpylt7pxMwr9_KuE130_assertion wasDerivedFrom befree-20140225 NP834470.RA8C1vE6gI8aKLcwPcA3LzIvOSEqcgpylt7pxMwr9_KuE130_provenance.
- NP834470.RA8C1vE6gI8aKLcwPcA3LzIvOSEqcgpylt7pxMwr9_KuE130_assertion wasGeneratedBy ECO_0000203 NP834470.RA8C1vE6gI8aKLcwPcA3LzIvOSEqcgpylt7pxMwr9_KuE130_provenance.